Connect
MJA
MJA

Enhancing hepatitis C treatment in the custodial setting: a national roadmap

Michael M Mina, Paul J Clark, Holly M Beasley, Lilie Herawati, Tony G Butler and Andrew R Lloyd
Med J Aust 2014; 200 (1): 15-16. || doi: 10.5694/mja13.10654

Challenges and opportunities for enhanced services

Over 300 000 Australians have been exposed to hepatitis C virus (HCV), of whom an estimated 226 700 are living with chronic infection, including 16 000 Indigenous Australians.1,2 Transmission of HCV occurs via blood-to-blood contact, most notably via injecting drug use.3 About 10 000 new infections are estimated to occur annually, and only 25% of infected individuals clear the virus during acute infection. Accordingly, the population living with chronic infection is steadily increasing.3,4 Over the next 20–40 years, about 20% of individuals with chronic hepatitis C are estimated to progress to cirrhosis,5 and thereafter 3% will die each year from liver failure or hepatocellular carcinoma.6 Chronic hepatitis C is already the leading indication for liver transplantation in Australia.4

  • Michael M Mina1
  • Paul J Clark2,3
  • Holly M Beasley4
  • Lilie Herawati5
  • Tony G Butler6
  • Andrew R Lloyd1

  • 1 Inflammation and Infection Research Centre, School of Medical Sciences, University of New South Wales, Sydney, NSW.
  • 2 Department of Gastroenterology, Princess Alexandra Hospital, Brisbane, QLD.
  • 3 Cancer Control Unit, Queensland Institute of Medical Research, Brisbane, QLD.
  • 4 Department of Corrective Services, Government of Western Australia, Perth, WA.
  • 5 Medical Department, MSD Australia, Sydney, NSW.
  • 6 Justice Health Research Program, Kirby Institute, University of New South Wales, Sydney, NSW.


Acknowledgements: 

The workshop was funded by MSD Australia, and attendees included: John Bate, Royal Adelaide Hospital; Lyn Burke, Townsville Hospital; Jacqueline Clegg, Justice and Forensic Mental Health Network; Anton Colman, Royal Adelaide Hospital; Crystal Connelly, Fremantle Hospital; Marian Croft, Western Hospital, Victoria; Peter Frost, South Australian Prison Health Service; Katarnya Gilbert, MSD Australia; Luke Grant, Corrective Services NSW; Margaret Hellard, Burnet Institute; Stuart Loveday, Hepatitis NSW; Denise Monkley, Justice and Forensic Mental Health Network; Katherine Mellor, St Vincent’s Hospital Melbourne; Jo Sexton, Princess Alexandra Hospital; Deborah Siddall, Correctional Primary Health Service, Tasmania; Poni Tongun, Marngoneet Correctional Centre; Helen Tyrrell, Hepatitis Australia; James Ward, Baker IDI Heart and Diabetes Institute; Lorraine Yap, Kirby Institute; Amany Zekry, St George Hospital.

Competing interests:

Lilie Herawati is entitled to MSD stocks as part of her employment.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.